Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoHive Medical, formerly HD LifeSciences, is a private U.S. medical device company focused on 3D-printed spinal interbody fusion implants and related instrumentation. Its core differentiator is the proprietary Soft Titanium lattice technology, a biomimetic titanium architecture designed to reduce implant stiffness, improve imaging characteristics, and support bony ingrowth for spinal fusion procedures. The company markets a Hive portfolio spanning cervical, anterior lumbar, oblique anterior lumbar, posterior lumbar, and transforaminal lumbar interbody systems. NanoHive has been expanding commercialization through independent distributors and strategic distribution partners, while also pursuing next-generation smart spinal implant capabilities through a collaboration and sublicense arrangement involving DirectSync technology. The company appears to be an active commercial-stage spine device business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoHive Medical.